Literature DB >> 21619720

Ethyl glucuronide, ethyl sulfate, and ethanol in urine after intensive exposure to high ethanol content mouthwash.

Gary M Reisfield1, Bruce A Goldberger, Amadeo J Pesce, Bridgit O Crews, George R Wilson, Scott A Teitelbaum, Roger L Bertholf.   

Abstract

To determine the degree of ethanol absorption and the resultant formation and urinary excretion of its conjugated metabolites following intensive use of high ethanol content mouthwash, 10 subjects gargled with Listerine(®) antiseptic 4 times daily for 3¼ days. First morning void urine specimens were collected on each of the four study days and post-gargle specimens were collected at 2, 4, and 6 h after the final gargle of the study. Urine ethanol, ethyl glucuronide (EtG), ethyl sulfate (EtS), and creatinine were measured. Ethanol was below the positive threshold of 20 mg/dL in all of the urine specimens. EtG was undetectable in all pre-study urine specimens, but two pre-study specimens had detectable EtS (6 and 82 ng/mL; 16 and 83 μg/g creatinine). Only one specimen contained detectable EtG (173 ng/mL; 117 μg/g creatinine). EtS was detected in the urine of seven study subjects, but was not detected in the single specimen that had detectable EtG. The maximum EtS concentrations were 104 ng/mL and 112 μg/g creatinine (in different subjects). Three subjects produced a total of eight (non-baseline) urinary EtS concentrations above 50 ng/mL or 50 μg/g creatinine and three EtS concentrations exceeding 100 ng/mL or 100 μg/g creatinine. In patients being monitored for ethanol use by urinary EtG and EtS concentrations, currently accepted EtG and EtS cutoffs of 500 ng/mL are adequate to distinguish between ethanol consumption and four times daily use of high ethanol content mouthwash.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21619720     DOI: 10.1093/anatox/35.5.264

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  11 in total

Review 1.  Alcohol Biomarkers in Clinical and Forensic Contexts.

Authors:  Hilke Andresen-Streichert; Alexander Müller; Alexander Glahn; Gisela Skopp; Martina Sterneck
Journal:  Dtsch Arztebl Int       Date:  2018-05-04       Impact factor: 5.594

2.  Preliminary investigations on ethyl glucuronide and ethyl sulfate cutoffs for detecting alcohol consumption on the basis of an ingestion experiment and on data from withdrawal treatment.

Authors:  Maria Elena Albermann; Frank Musshoff; Elke Doberentz; Peter Heese; Markus Banger; Burkhard Madea
Journal:  Int J Legal Med       Date:  2012-06-30       Impact factor: 2.686

3.  Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.

Authors:  Peter I Jatlow; Ann Agro; Ran Wu; Haleh Nadim; Benjamin A Toll; Elizabeth Ralevski; Christine Nogueira; Julia Shi; James D Dziura; Ismene L Petrakis; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

4.  Commercial Ethyl Glucuronide (EtG) and Ethyl Sulfate (EtS) Testing is Not Vulnerable to Incidental Alcohol Exposure in Pregnant Women.

Authors:  Steven J Ondersma; Jessica R Beatty; Thomas G Rosano; Ronald C Strickler; Amy E Graham; Robert J Sokol
Journal:  Subst Use Misuse       Date:  2016-01-15       Impact factor: 2.164

5.  Assessment of exposure to alcohol vapor from alcohol-based hand rubs.

Authors:  Vincent Bessonneau; Olivier Thomas
Journal:  Int J Environ Res Public Health       Date:  2012-03-13       Impact factor: 3.390

Review 6.  Biomolecules and Biomarkers Used in Diagnosis of Alcohol Drinking and in Monitoring Therapeutic Interventions.

Authors:  Radu M Nanau; Manuela G Neuman
Journal:  Biomolecules       Date:  2015-06-29

7.  Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations.

Authors:  Charles E Argoff; Daniel P Alford; Jeffrey Fudin; Jeremy A Adler; Matthew J Bair; Richard C Dart; Roy Gandolfi; Bill H McCarberg; Steven P Stanos; Jeffrey A Gudin; Rosemary C Polomano; Lynn R Webster
Journal:  Pain Med       Date:  2018-01-01       Impact factor: 3.750

8.  Oral rinses in growth inhibition and treatment of Helicobacter pylori infection.

Authors:  Dharmendra Kashyap; Budhadev Baral; Tarun Prakash Verma; Charu Sonkar; Debi Chatterji; Ajay Kumar Jain; Hem C Jha
Journal:  BMC Microbiol       Date:  2020-03-04       Impact factor: 3.605

9.  VOC contamination in hospital, from stationary sampling of a large panel of compounds, in view of healthcare workers and patients exposure assessment.

Authors:  Vincent Bessonneau; Luc Mosqueron; Adèle Berrubé; Gaël Mukensturm; Sylvie Buffet-Bataillon; Jean-Pierre Gangneux; Olivier Thomas
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

10.  Blood Phosphatidylethanol Concentrations Following Regular Exposure to an Alcohol-Based Mouthwash.

Authors:  Gary M Reisfield; Scott A Teitelbaum; Joseph T Jones; Dana Mason; Max Bleiweis; Ben Lewis
Journal:  J Anal Toxicol       Date:  2021-11-09       Impact factor: 3.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.